Evidence map›Paper›PMID 40882162›Full record

ArticleNeurology(R) neuroimmunology & neuroinflammation2025

Influence of OSCAR-IB Criteria on Test-Retest Reliability of Cirrus HD-OCT Retinal Thickness Measurements in People With Multiple Sclerosis.

Anna Bacchetti, Ting-Yi Lin, Brenna McCormack, Omar Ezzedin, Rozita Doosti, Gelareh Ahmadi, Nicole Pellegrini, Evan Johnson, Simidele Davis, Elle Lawrence and 11 more

Abstract read
In one paragraph

Article in Neurology(R) neuroimmunology & neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Anna BacchettiDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0009-0000-9434-8531
Ting-Yi LinDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0001-9605-8095
Brenna McCormackDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0009-0002-6678-7021
Omar EzzedinDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0009-0006-9842-4099
Rozita DoostiDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0001-9811-9154
Gelareh AhmadiDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-5315-4498
Nicole PellegriniDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-7181-2562
Evan JohnsonDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Simidele DavisDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0009-0006-4602-3955
Elle LawrenceDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Gabriel Otero-DuranDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Ernest LieversDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Madeline InserraDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Sooyeon ParkDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Devon BonairDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Anna KimDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Ananya GulatiDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0009-0008-9304-3224
Kathryn C FitzgeraldDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0003-3137-0322
Elias S SotirchosDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-8812-1637
Peter A CalabresiDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-7776-6472
Shiv SaidhaDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0001-6387-0714

Funding

Imaging Neurodegeneration in Multiple SclerosisR01NS082347 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PETER A CALABRESI, Shiv Saidha · 2013 to 2026
$7.0M
NINDS NIH HHS R01 NS082347
6 · The paper itself

Abstract

BACKGROUND AND

objectivesOptical coherence tomography (OCT) allows evaluation of inter-eye differences (IEDs) in macular ganglion cell-inner plexiform layer (GCIPL) and peripapillary retinal nerve fiber layer (pRNFL) thicknesses to identify unilateral optic nerve involvement (UONI). UONI supports dissemination in space (DIS) as part of the 2024 revised McDonald diagnostic criteria for multiple sclerosis (MS). The OSCAR-IB quality control (QC) criteria identify suboptimal-quality OCT scans, which could potentially result in false-positive or false-negative UONI identification. We aimed to determine the influence of scans fulfilling OSCAR-IB criteria (SFO) and not fulfilling (SNFO) on test-retest reliability of pRNFL and GCIPL thicknesses/IEDs, with a commonly used OCT platform (Cirrus HD-OCT).

methodsA total of 509 participants, including 397 people with MS, underwent Cirrus HD-OCT, with acquisition of 2 macular and optic disc scans per eye. Each scan was classified as either SFO or SNFO. There were no clinical or demographic exclusions in order to reflect a real-world clinical setting. Reproducibility was evaluated with intravisit intraclass correlation coefficients (ICCs) and coefficients of variation (COVs). IED consistency was assessed with difference-in-differences (DiDs) and probabilities of agreement (POA) for specific IED thresholds (GCIPL </≥4; pRNFL </≥6 μm).

resultsA total of 1,143 macular scan pairs (1,100 SFO and 42 SNFO) for GCIPL and 1,108 optic disc scan pairs (1,003 SFO and 105 SNFO) for pRNFL were analyzed. SFO demonstrated superior reliability, as compared to SNFO for GCIPL (SFO: ICC = 0.998, COV = 0.40%; SNFO: ICC 0.353, COV 10.14%) and pRNFL (SFO: ICC = 0.989, COV = 1.18%; SNFO: ICC = 0.852, COV = 3.94%) thicknesses. DiDs were lower for SFO (GCIPL 0.64 ± 0.67 μm, pRNFL: 2.00 ± 1.72 μm), as compared to SNFO (GCIPL: 10.17 ± 13.87 μm, pRNFL: 4.78 ± 5.51 μm). POA of IED thresholds (GCIPL: </≥4; pRNFL: </≥6 μm) was higher for SFO than for SNFO (GCIPL: 95.58% vs 47.83%; pRNFL: 86.89% vs 71.67%). DISCUSSION: GCIPL and pRNFL thicknesses/IEDs demonstrated markedly inferior reliability in SNFO, relative to SFO. Failure to fulfill OSCAR-IB criteria influenced pRNFL measurements and, in particular, GCIPL measurements, highlighting the importance of thorough QC in the interpretation of OCT to correctly identify UONI and accurately support DIS for the diagnosis of MS.

Indexed as

Multiple SclerosisRetinaTomography, Optical CoherenceAdultFemaleHumansMaleMiddle AgedNerve FibersReproducibility of ResultsRetinal Ganglion Cells

Identifiers

PMID40882162
PMCPMC12401565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.